Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CSN2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PNPO - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KIAA0226L - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NDUFA4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MED16 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MRP63 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SERF2-C15ORF63 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
RRBP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MYOF - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PRAMEF11 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MIR4738 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SYT11 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ACAN - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CDIPT - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ASAP3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NSA2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MRTO4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PTGES - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FARSA - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
B2M - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on